Sorafenib Tosylate Patent Expiration

Sorafenib Tosylate is Used for treating advanced renal cell carcinoma, carcinoma of the thyroid, and unresectable hepatocellular carcinoma. It was first introduced by Bayer Healthcare Pharmaceuticals Inc in its drug Nexavar on Dec 20, 2005. 6 different companies have introduced drugs containing Sorafenib Tosylate.


Sorafenib Tosylate Patents

Given below is the list of patents protecting Sorafenib Tosylate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Nexavar US9737488 Pharmaceutical composition for the treatment of cancer Sep 10, 2028 Bayer Hlthcare
Nexavar US8877933 Thermodynamically stable form of a tosylate salt Dec 24, 2027 Bayer Hlthcare
Nexavar US8618141 Aryl ureas with angiogenesis inhibiting activity Feb 11, 2023

(Expired)

Bayer Hlthcare
Nexavar US7235576 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Jan 12, 2020

(Expired)

Bayer Hlthcare
Nexavar US7351834 ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Jan 12, 2020

(Expired)

Bayer Hlthcare
Nexavar US7897623 ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors Jan 12, 2020

(Expired)

Bayer Hlthcare
Nexavar US8124630 ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Jan 12, 2020

(Expired)

Bayer Hlthcare
Nexavar US8841330 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors Jan 12, 2020

(Expired)

Bayer Hlthcare



Sorafenib Tosylate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sorafenib Tosylate Generic API Manufacturers

Several generic applications have been filed for Sorafenib Tosylate. The first generic version for Sorafenib Tosylate was by Mylan Pharmaceuticals Inc and was approved on Sep 10, 2020. And the latest generic version is by Torrent Pharmaceuticals Ltd and was approved on Apr 12, 2023.

Given below is the list of companies who have filed for Sorafenib Tosylate generic, along with the locations of their manufacturing plants worldwide.


1. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Sorafenib Tosylate. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet Prescription ORAL AB Jun 7, 2022





2. MYLAN

Mylan Pharmaceuticals Inc has filed for 1 generic for Sorafenib Tosylate. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet Prescription ORAL AB Sep 10, 2020


Manufacturing Plant Locations
New

Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.

Country City Firm Name
United States
Santa Barbara Mylandon LLC dba Debbie s Delights Santa Barbara Baking Co.
San Carlos Mylan Pharmaceuticals Inc.
Saint Albans Mylan Technologies, Inc.
Morgantown Mylan Specialty, L.P.
Greensboro Mylan Pharmaceuticals Inc
Morgantown MYLAN CONSUMER HEALTHCARE Inc.
Rockford Mylan Institutional, Inc.
India
Anekal Taluk, Bangalore Mylan Laboratories Limited
Sinnar Mylan Laboratories Limited
Hosur Mylan Laboratories Limited
Hyderabad Mylan Laboratories Limited
Bangalore Mylan Laboratories Limited
Sarigam Mylan Laboratories Limited
Aurangabad Mylan Laboratories Limited (FDF-2)
Pithampur, District Dhar Mylan Laboratories Limited
Canada
Etobicoke Mylan Pharmaceuticals ULC
Ireland
Inverin Mylan Teoranta





3. TEVA PHARMS USA INC

Teva Pharmaceuticals Usa Inc has filed for 1 generic for Sorafenib Tosylate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet Prescription ORAL AB Nov 12, 2020





4. TORRENT

Torrent Pharmaceuticals Ltd has filed for 1 generic for Sorafenib Tosylate. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet Prescription ORAL AB Apr 12, 2023


Manufacturing Plant Locations
New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country City Firm Name
India
Bharuch Torrent Pharmaceuticals Limited
Pithampur Torrent Pharmaceuticals Limited
Thanam Torrent Pharmaceuticals Limited
Gandhi Nagar Torrent Pharmaceuticals Limited
Indrad Torrent Pharmaceuticals Limited
United States
Basking Ridge Torrent Pharma Inc.
Kalamazoo Torrent Pharma Inc.





5. YABAO PHARM

Yabao Pharmaceutical Co Ltd Beijing has filed for 1 generic for Sorafenib Tosylate. Given below are the details of the strengths of this generic introduced by Yabao Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 200MG BASE

tablet Prescription ORAL AB Nov 9, 2022


Manufacturing Plant Locations
New

Yabao Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Yabao Pharm as present at those locations.

Country City Firm Name
China
Tongzhou Yabao Pharmaceutical Co., Ltd. Beijing
Yuncheng Yabao Pharmaceutical Group Co., Ltd